NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF · Real-Time Price · USD
1.870
-0.030 (-1.58%)
Aug 14, 2025, 11:50 AM - Market open

Company Description

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan.

The company’s fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing.

It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment.

The company offers its services through its clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

NewGenIvf Group Limited
NewGenIvf Group logo
CountryThailand
Founded2011
IndustryMedical Care Facilities
SectorHealthcare
Employees76
CEOWing Fung Siu

Contact Details

Address:
PS Tower, 13th Floor, Unit 36/39-36/40
Bangkok, 10110
Thailand
Phone66 2 116 9641
Websitenewgenivf.com

Stock Details

Ticker SymbolNIVF
ExchangeNASDAQ
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001981662
CUSIP NumberG0544E303
ISIN NumberVGG0544E3032
SIC Code8090

Key Executives

NamePosition
Wing Fung SiuCo-Founder, Chairman and Chief Executive Officer
Hei Yue FongCo-Founder, Chief Marketing Officer and Director
Fai Chung HoChief Financial Officer

Latest SEC Filings

DateTypeTitle
Jul 28, 20256-KReport of foreign issuer
Jul 21, 20256-KReport of foreign issuer
Jul 16, 20256-KReport of foreign issuer
Jul 7, 20256-KReport of foreign issuer
Jul 1, 20256-KReport of foreign issuer
Jun 20, 20256-KReport of foreign issuer
Jun 17, 20256-KReport of foreign issuer
Jun 4, 20256-KReport of foreign issuer
Jun 3, 2025EFFECTNotice of Effectiveness
Jun 3, 2025424B3Prospectus